LM 2A Protection & Comfort PDF - NUR 370
Document Details

Uploaded by LionheartedChrysoprase8638
University of Rochester
Rebecca Young
Tags
Summary
This document, titled Learning Module 2A: Protection & Comfort, is a set of notes covering the autonomic nervous system and immune system. The module details the sympathetic and parasympathetic nervous systems, adrenergic and cholinergic receptors, and immune responses. It includes various mechanisms of action, indications, and adverse effects of related medications. Questions are also present at the end of the document.
Full Transcript
# Learning Module 2A: Protection & Comfort ## NUR 370 ## Rebecca Young, MS, RN, CCRN ## Learning Objectives - Describe the sequence of events in the immune and inflammatory responses. - Discuss the role of anti-inflammatory agents and immunizations in mitigating the inflammatory response and pre...
# Learning Module 2A: Protection & Comfort ## NUR 370 ## Rebecca Young, MS, RN, CCRN ## Learning Objectives - Describe the sequence of events in the immune and inflammatory responses. - Discuss the role of anti-inflammatory agents and immunizations in mitigating the inflammatory response and prevention of diseases. - Differentiate between normal and abnormal anatomy and physiology of the autonomic nervous system. - Determine the mechanism of action, indication(s) and expected/unexpected outcomes of medications impacting protection and comfort. # Autonomic Nervous System - Regulates homeostasis of the body's normal functions through CNS, PNS, and endocrine responses. - Nerve impulses in PNS are sent to thalamus, medulla, & spinal cord (CNS). - From the CNS, impulses are sent out to stimulate organs, glands, muscles. - Blood pressure, heart rate, respiratory rate, temperature, fluid status, urinary output, digestion. - Parasympathetic vs Sympathetic. # Sympathetic Nervous System - “Fight-or-flight”: response to a stressor. - CNS cells in thoracic and lumbar areas of spinal cord stimulate nerve ganglia. - Neurotransmitters released; primarily norepinephrine and epinephrine. - Because the body is attempting to survive, it picks organ systems that are most beneficial: ↑ heart rate, ↑ blood pressure, ↑ respiratory rate, bronchodilation, pupil dilation, breakdown of glucose. - Elimination, digestion, reproduction all slow. # Adrenergic/Sympathetic Receptors - Alpha and Beta receptors that respond to circulating epinephrine and norepinephrine. - Alpha1, Alpha2, Beta1, Beta2. - Respond differently based on concentrations of neurotransmitters. - Some drugs may be specific to receptor type, others stimulate all receptors. - More specific drugs result in less systemic side effects. # Adrenergic Agonists - Alpha and Beta Adrenergic Agonist; dopamine, epinephrine. ## Mechanism of Action - **Dopamine:** Increased HR, increased BP; preserves blood flow to kidneys; treats shock. - **Epinephrine:** Vasoconstriction, increased HR, increased BP, bronchodilation; treats shock, severe bronchospasm (asthma), anaphylaxis. ## Pharmacokinetics - IV or IM. ## Contraindications - Pheochromocytoma. - Tachyarrhythmias, Ventricular fibrillation. - Hypovolemia (give fluids). ## Adverse Effects - **Effects on the heart/CV:** Arrhythmias, hypertension, palpitations, angina, dyspnea. - **Depressant effects on the GI tract:** Nausea, vomiting, constipation. - **Sympathetic stimulation effects**: Headache, sweating, feelings of tension or anxiety, and piloerection. # Nonselective Adrenergic Blocking Agents - Nonselective adrenergic blocking agents; labetalol ## Mechanism of Action - Blocks the effects of norepinephrine at alpha and beta-receptors throughout the SNS, decreasing BP, HR and improving renal perfusion. - Treats hypertension and tachycardia. ## Pharmacokinetics - Oral or IV. ## Contraindications - Bradycardia, heart block, asthma. - Caution with clients diagnosed with diabetes (masks symptoms of hypo/hyperglycemia). ## Adverse Effects - Bradycardia, hypotension, bronchospasm, cough. ## Client/Therapy Management - Monitor HR, BP, & blood glucose. # Parasympathetic Nervous System - “Rest and digest”: slows metabolism/function to conserve energy. - CNS cells in cranium and sacral areas of spinal cord stimulate nerve ganglia. - Neurotransmitters released; acetylcholine. - Conserve energy, build up proteins and nutrients, increase digestion: ↑ motility/secretions in GI tract, ↓ heart rate, bronchoconstriction, relaxation of sphincters, contraction of urinary bladder, pupil constriction. # Cholinergic/Parasympathetic Receptors - Receptors found in muscle or organs - Muscarinic or nicotinic - Respond differently based on concentrations of neurotransmitters. - Drugs tend to stimulate all cholinergic receptors, so see systemic effects throughout the body. - Some drugs are specific to muscarinic vs. nicotinic receptors. # Direct-Acting Cholinergic Agonists - Direct-Acting Cholinergic Agonists; bethanechol ## Mechanism of Action - Mimics acetylcholine and parasympathetic stimulation - Treats urinary retention, atonic bladder; glaucoma. ## Pharmacokinetics - Oral. ## Contraindications - Bradycardia, hypotension, and coronary artery disease. ## Adverse Effects - **Systemic effects of parasympathetic stimulation:** Bradycardia, hypotension, heart block. - **Bladder Spasm:** # Stress Response - Homeostasis: maintenance of stable internal environment. - Threatened during a stress response. - Ideally, stress responses should be acute. If chronic, issues result with a suppressed immune system and increased energy demands; body begins to break down. - Stress response is designed protect the body but if overwhelmed, can cause damage to the body. - Control systems and feedback mechanisms in place to regulate cell function. # Control Systems/Feedback Mechanisms - Control systems integrate the body’s responses to stressors (physical, emotional, behavioral) and create a stress response. - **Sensor:** detects the change — **Integrator**: assesses incoming information and compares it to “normal” — **Effector:** attempts to reverse the change. # Negative Feedback System - Decrease occurs of substance, body stimulated to increase it// increase occurs of substance, body stimulated to decrease it. # General Adaptation Syndrome (GAS) - HPA axis plays a large role in stress response (hypothalamus-pituitary-adrenal). - Regulates ANS and neurotransmitter release. - 3 stages: alarm, resistance, fatigue. ## Alarm - Stimulation of sympathetic nervous system. - HPA axis stimulated; epinephrine, norepinephrine, dopamine, cortisol release. ## Resistance - Most efficient defenses are initiated. - Cortisol decreases. ## Fatigue - Stressor is prolonged or overwhelms the body. - Resources are depleted. - Systemic damage to the body occurs. # Conditioning Factors: How do Different People Respond and Adapt to Stress? - Age, genetics, sex, life experience, nutrition, social support. - Body reserve, health status, circadian rhythm, hardiness (control over environment + purpose in life), psychosocial factors. # Acute Stress - Should be an acute and time-limited trigger. - Fight-or-flight response (SNS): pounding headache, increased vital signs, increased alertness, blood diverted away from less essential organs. - Client with limited coping may develop stress-induced disease processes: anxiety, depression, eating disorders, sleep disorders, high blood pressure (hypertension), pain, infection, migraine. # Chronic Stress - Chronic intermittent; stressor exposed to many times, over time. - Chronic sustained; stressor exposed to constantly, does not dissipate. - HPA axis becomes overactive or underactive: - Failure in neural or hormonal connections. - Stressor stimulus is prolonged. - Stressor stimulus is so great it overwhelms the system. - Impacts cardiac, immune, neurological gastrointestinal, substance use, mental health. # Learning Module 2B: Protection & Comfort ## NUR 370 ## Rebecca Young, MS, RN, CCRN ## Learning Objectives - Describe the sequence of events in the immune and inflammatory responses. - Discuss the role of anti-inflammatory agents and immunizations in mitigating the inflammatory response and prevention of diseases. - Differentiate between normal and abnormal anatomy and physiology of the autonomic nervous system. - Determine the mechanism of action, indication(s) and expected/unexpected outcomes of medications impacting protection and comfort. # Adaptive vs Innate Immunity - **Adaptive**: against specific pathogens or changed body cells. - **Innate**: against foreign bodies, injuries and pathogens. ## Adaptive Immunity - Defense cells in the blood: B lymphocytes. - Antibodies. - Defense cells in the tissue: T lymphocytes. ## Innate Immunity - Bacteria-killing substances. - Protection on the outside: the skin. - Protection on the inside: all mucous membranes. - First attack in the tissue: scavenger cells. # Barrier Defenses - **Skin**: first line of defense to protect tissues and organs. - Glands secrete chemicals to destroy pathogens. - Skin sheds daily to rid of any pathogens. - Normal bacterial flora. - **Mucous membranes**: line the respiratory tract, gastrointestinal tract, genitourinary tract. - Creates mucus to trap pathogens. - Protects GI cells from stomach acid/digestive enzymes. - **Gastric acid**: destroys ingested pathogens. - Normal gastric flora. - **Major histocompatibility complex (MHC)**: histocompatibility antigens embedded in cell membranes. - Distinguishes self cells vs. non-self cells. - Cells that do not have histocompatibility antigens are destroyed by the body. # Protein Defenses - **Complement proteins**: destroy antigen through many processes. - Alter cell membrane: fluid moves into pathogen and pathogen bursts and is destroyed. - Chemotaxis: attracts phagocytes to the site of the pathogen. - Increases phagocytosis by neutrophils. - Stimulates inflammatory response: histamine release, vasodilation, increased blood flow and blood cells to area. # Cellular Defenses - Stem cells in bone marrow produce leukocytes (white blood cells). - **Lymphocytes**: T cells, B cells, natural killer cells. - **Myelocytes**: neutrophils, basophils, eosinophils, monocytes/macrophages. # Lymphoid Tissues - Lymph nodes, thymus, bone marrow, portions of respiratory and GI tract. - Play a role in creation and regulation of immune cells. # Immune Response - Specific pathogen invasion can stimulate a specific immune response through lymphocytes. - **T cells**: made in bone marrow, migrate to the thymus to be matured and activated. - **Effector/cytotoxic**: respond to non-self cells; release cytokines to destroy cell or mark it for destruction by phagocytes during inflammatory response. - **Helper**: stimulate B cells to be more aggressive and responsive. - **Suppressor**: slows immune response to allow body to conserve energy and prevent further cellular destruction. - Helper and Suppressor T cells balance each other to allow for quick initial reaction to destroy pathogens, yet preserve further cell destruction. - **B cells:** programmed to identify specific antigens. - B cell reacts with antigen and forms an antigen-antibody complex which activates complement proteins. - **Plasma cell (IgM)**: antibodies produced at first exposure. - **Memory cell (IgG)**: antibodies made for later exposure to same pathogen — quick release. # Other Immune Mediators - **Interferons**: cytokines (chemicals) that are secreted by cells invaded by a virus. - Prevent viral replication, suppress malignant cell replication, suppress tumor growth. - **Interleukins**: cytokines secreted by active leukocytes. - Stimulate T and B cells to mount immune response. - **Tumor necrosis factor (TNF)**: secreted by macrophages to inhibit tumor growth and increases effectiveness of immune and inflammatory responses. # Question - The body is exposed to injected antibodies, referred to as immunoglobulins. What form of immunity is this? - Active natural immunity. - Passive natural immunity. - **Passive artificial immunity.** - Active artificial immunity. # Active immunity - Host mounts an immune response to an antigen and produces antibodies. - Immune system develops memory of the antigen. - T cells and Memory B cells will respond on future exposures. ## Active Artificial Immunity - Antigen is administered similar to a pathogen antigen - vaccination. ## Active Natural Immunity - Antigen enters the body through environmental exposure - infection. # Passive Immunity - Antibodies are transferred from another source; lasts weeks to months. ## Passive Artificial Immunity - Administer antibodies intravenously (immunoglobulins). ## Passive Natural Immunity - IgG antibodies from mother to fetus through the placenta or breast milk. # Vaccination/Immunization - Artificial active immunity: body is exposed to weakened proteins associated with specific disease. - Bacterial cell membrane, protein coat of virus, weakened virus, chemically inactivated organisms, weakened toxins. - Caution used for those with immunosuppression: vaccine could cause actual disease. - Caution with acute infection, immunosuppressant drugs, stress on the body. # Inflammatory Response Overview - Injury to cells or tissue causes chemical reactions and a cascade of events. - Goal to remove the invader, limit tissue damage, and restore homeostasis. - Two stages: - Vascular stage: increased blood flow to injured tissues. - Cellular stage: leukocytes (WBCs) move into tissues - Can be acute (minutes to hours) or chronic (days to years). # Inflammatory Response Cells - **Endothelial cells**: line the blood vessels and allow selective permeability; vasoconstrict and vasodilate. - **Platelets**: release inflammatory mediators which increase vessel permeability. - **Neutrophils**: phagocytic - destroy invaders in the tissues - **Leukocytosis**: increase in number of neutrophils in the blood during inflammatory response; only live for 10 hours and must be present to respond to infection injury. - **Monocytes/macrophages**: phagocytic - destroy invaders in tissues. - Produce inflammatory mediators. # Inflammatory Response - Initial injury activates Hageman factor (factor XII): activates the kinin system — vascular stage begins. ## Vascular Stage - Quick vasoconstriction of vessels for seconds, then vasodilate. - **Bradykinin release**: local vasodilation, increased capillary permeability, stimulates nerve endings to cause pain. - Cell membrane releases arachidonic acid which activates chemicals that increase inflammatory response; prostaglandins, leukotrienes, cyclooxygenase, thromboxanes. # Inflammatory Response - **Vascular stage**: - **Histamine release**: vasodilation, increased blood flow, increased capillary permeability, stimulates pain perception. - Vasodilation causes tissue congestion; red, warm, swollen. - Neutrophils are brought to and enter tissues, then eliminate invader or injured cells. ## Cellular Stage - Changes occur on the vessel linings to allow leukocytes to stop and adhere to vessel. - This then allows the leukocyte to move from the vessel into the injured tissue. - Leukocytes are then attracted to site of inflammation through chemotaxis. - Upon arrival at the tissue, monocytes, neutrophils, and macrophages engulf bacteria or injured cell through phagocytosis. # The Inflammatory Response in Relation to the Four Cardinal Signs of Inflammation - **Exposure of plasma to injured cell, etc.** → **Activation of Hageman Factor** → **Prekallikrein** → **Active kallikrein** → **Kininogen** → **Bradykinin** → **Release of arachidonic acid** → **↑ Capillary permeability** → **Vasodilation** → **Leukotrienes (LTs)** → **Prostaglandins (PGs)** → **Exudation of plasma proteins** → **Edema** → **↑ Blood Flow** → **Chemotaxis of leukocytes, Activation of neutrophils** → **Dolor (pain)** → **Tumor (swelling)** → **Rubor (redness)** → **Calor (heat)** → **Phagocytosis** → **Removal of debris and preparation of injured site for healing** # Manifestations of Local Inflammation - Related primarily to vasodilation and increased capillary permeability. - Increased blood flow, fluid leaks into tissues, congestion of tissues occurs. - 5 cardinal signs: pain (dolor), swelling (tumor), redness (rubor), warmth (calor), loss of function. # Pyrogen - Released once cellular phase occurs; can result in fever. # Manifestations of Systemic Inflammation - Inflammatory mediators are released into circulation and cause a widespread response: leukocytes, cytokines, erythrocyte sedimentation rate (ESR). - Vasodilation, large increase in capillary permeability, loss of fluid in vessels (moves into tissues), can lead to hypotension and shock (low BP that causes depressed organ function/damage). # Inflammatory + Immune Response - Both responses work together to maintain homeostasis. - Hageman factor and histamine cause increased capillary permeability that allows for neutrophils to get to damaged tissues and destroy pathogens. - Inflammatory reaction continues to activate leukocytes. - Inflammatory reaction destroys invader cells through phagocytosis that have been marked by T cells. # Pain Summary - An unpleasant sensation + emotional experience related to actual or potential tissue damage. - When tissues are damaged, cells release chemicals such as kinins and prostaglandins which stimulate sensory nerves. - Acute pain; surgery, injury, infection. - Chronic pain; constant or intermittent. - Nociceptive pain: direct stimulus to pain receptor. - Neuropathic pain: nerve injury or nerve dysfunction (sensory axons). - Psychogenic pain: emotional, behavioral, psychological. # Patho of Pain - Nociception: transmission of unpleasant stimuli from area of injury to the brain via sensory nerve fibers. - **A-delta fibers**: respond quickly to acute pain, myelinated. - **C fibers**: slow to conduct, unmyelinated; persistent stimuli (chronic pain). - **Pain impulses sent from tissues/organs to the spinal cord** - **A fibers**: transmit sensations associated with pressure, stretch, vibration. - Large fibers, conduct most quickly. - Can block smaller fibers. # Patho of Pain - **Gate Control Theory**: transmission of the impulses to the brain can be blocked at any point. - Interneurons in spinal cord. - A fibers (touch fibers) compete with smaller fibers. - Descending impulses from cerebral cortex, limbic system, reticular activating system; serotonin and norepinephrine. - Some truth to this, but not this simple; many other factors contribute to experiencing pain. - Pain receptors, neurotransmitters, learning, culture, tolerance. # Pain Pathway - **Tissue Injury** → **Inflammatory Mediators Released** → **Stimulate Nerve Fibers** → **Dorsal Horn of Spinal Cord** → **Spinothalamic Tracts** → **RAS** → **Cerebral Cortex** - **Nerve Endings:** detect stimuli that cause tissue damage. - **Dorsal Horn of Spinal Cord:** process the sensation of pain. - **Thalamus/Cerebral Cortex:** integrate pain + pain sensation occurs — client’s subjective reaction. # Mechanism of Acute Pain - **Nociceptor** → **Mediator release** → **Inflammation** → **Tissue Injury** → **Substance P, Prostaglandins, Serotonin, Acetylcholine** → **Pain**, → **Somatosensory cortex** → **Thalamus, RAS** → **Spinothalamic Pathway** # Pain Receptors - Some receptors respond to all stimuli, some are specific. - Thermal: temperature extremes. - Mechanical: stretch, pressure, violent contraction. - Chemical: tissue trauma, ischemia, inflammation. - Inflammatory response to painful stimulus becomes a loop: inflammatory mediators released from injured tissues stimulate pain receptors perpetuates the inflammatory response more inflammatory mediators released more pain occurs — # Pain Receptors - Opioid receptors found in CNS, peripheral nerves, GI cells. - Respond to endorphins and enkephalins; modulate pain information coming into the brain. - Brainstem: BP, nausea, vomiting, respiration, cough. - Integrate and communicate current info about pain. - Activate endocrine or neural response to pain. - Emotional response to pain. - Block neurotransmitters related to pain. # Types of Pain ## Acute Pain - Results from tissue injury. - Short duration, resolves once injury is treated or stimulus is removed. - Protective mechanism to alert you of tissue injury. - If untreated, prolonged stimulation of sympathetic nervous system (vital sign changes in HR, BP, RR). ## Chronic Pain - Persistent pain, often musculoskeletal, visceral, vascular. - Causes stressors; emotional, mental, physical. - Lacks sympathetic nervous system response. - Loss of appetite, insomnia, depression. # Acute vs Chronic Pain | Characteristic | Acute Pain | Chronic Pain | | - | - | - | | Onset | Recent | Continuous or intermittent | | Duration | Short (<3 months) | 3 months or more | | Autonomic Response | Consistent with sympathetic fight or flight response: Increased HR, BP, Increased RR, Pupillary dilation, Muscle tension, Decreased gut motility | Absence of autonomic responses | | Psychological Component | Associated anxiety | Increased irritability, associated depression, somatic preoccupation, withdrawal from outside interests, decreased strength of relationships | | Other types of responses | | Decreased sleep, decreased libido, appetite changes | # Question - What are examples of nonpharmacologic pain management? # Opioid Agonist - **Opiod Agonist**: morphine. ## Mechanism of Action - React with opioid receptors causing analgesia, sedation, euphoria. - Treats acute pain, and moderate to severe chronic pain. ## Pharmacokinetics - Oral, PR, SQ, IM, IV ## Contraindications - GI obstruction (paralytic ileus), other medications with CNS depression. ## Adverse Effects - Respiratory depression, hypotension, constipation, sedation, cough suppression. ## Client/Therapy Management - Monitor for sedation: no driving. - Monitor respirations/oxygen saturation: due to decrease respiratory drive. - Monitor for constipation: increase fiber and fluid intake, increase mobility. - Monitor for dependence and tolerance. # Opioid Agonist-Antagonist - **Opioid Agonist-Antagonist**: buprenorphine. ## Mechanism of Action - Stimulate certain opioid receptors, while blocking others. - Treat moderate to severe pain or opioid use disorders; chronic pain. ## Pharmacokinetics - Buccal, IM, IV, SQ implant ## Contraindications - Other medications with CNS depression. ## Adverse Effects - Respiratory depression, sedation, impaired mentation. - **Withdrawal syndrome if switching therapy:** abdominal cramps/pain, hypertension, anxiety, vomiting, fever, severe pain. ## Client/Therapy Management - Monitor for dependence: less risk than with opioid agonists. - Monitor for respiratory rate, oxygen saturation. - Monitor sedation.